Dynamic follow-up of the effects of programmed death 1 inhibitor treatment on thyroid function and sonographic features in patients with hepatocellular carcinoma

OBJECTIVE: Programmed cell death protein-1 (PD-1) inhibitors are widely used for the treatment of hepatocellular carcinoma (HCC). Thyroid dysfunction is common in patients treated with this therapy, although the dynamic changes in thyroid function and sonographic features remain unclear. METHODS: We...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Xiaoya, Xiao, Heng, Long, Jian, Wei, Qiang, Liu, Liping, Zan, Liping, Ren, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175608/
https://www.ncbi.nlm.nih.gov/pubmed/35521813
http://dx.doi.org/10.1530/EC-22-0065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175608/
https://www.ncbi.nlm.nih.gov/pubmed/35521813
http://dx.doi.org/10.1530/EC-22-0065

Ejemplares similares